The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Somnath Chatterjee
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The stock exchange received a disclosure under Regulation 29(2) of the SEBI Takeover Regulations from Dr Somnath Chatterjee, who is associated with Suraksha Diagnostic. This regulation requires promoters and persons acting in concert to disclose changes of 2% or more in their shareholding during a quarter. The headline does not specify whether the disclosure relates to an acquisition or a sale, or the exact quantum of shares involved. Such filings are routine compliance disclosures rather than fresh corporate actions. Investors should look at the detailed disclosure form to understand the exact transaction and its size.
This is a standard regulatory compliance filing and is unlikely to have a meaningful direct impact on the stock price on its own. Shareholders may want to check the underlying transaction details to track changes in promoter shareholding patterns.